News

Wall Street Trims Ratings for Novo Nordisk Stock, as Ozempic’s Competition Grows
Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...
Futurism on MSN11h
Novo Nordisk Is Getting Absolutely Destroyed
Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight-loss drugs Ozempic and ...
Daily Pill May Work as Well as Ozempic for Weight Loss and Blood Sugar
Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...
Eli Lilly Stock Soars on Weight-Loss News. Why It’s Bad for Novo Nordisk.
Eli Lilly said its new weight-loss pill had cleared a late-stage clinical trial, a promising sign as the company continues to ...
Novo Nordisk: A Price Too Low To Ignore
Novo Nordisk's stocks face YTD struggles due to trial results and tariffs, but strong fundamentals and outlook justify a Buy.
Novo Nordisk to invest $1.09 billion to boost Ozempic, Wegovy production in Brazil
Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...
Eli Lilly Shares Up 13% After Weight Loss Pill Appears As Effective As Ozempic And Mounjaro In Trials
Shares of Eli Lilly soared Thursday morning after the pharmaceutical giant announced a clinical trial of its once-daily ...
Fortune India4d
Exclusive: Novo Nordisk bets on India as Ozempic drives $43 billion global surge
Riding on a surge in global demand for its patented obesity and diabetes medicines Ozempic, Wegovy and Rybelsus, ...